Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option
.
Source: Expert Opinion on Drug Discovery - Category: Drugs & Pharmacology Authors: Sara FerraroIrma ConvertinoEmiliano CappelloGiulia ValdiserraMarco BonasoMarco Tuccoria Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa Italyb Unit of Adverse Drug Reaction Monitoring, Source Type: research